KIF23 Promotes Gastric Cancer by Stimulating Cell Proliferation

Figure 1

The expression level of KIF23 in tumor tissues was associated with the prognosis of patients who have gastric cancer. (a) Immunohistochemistry analysis of expression of KIF23 protein in gastric cancer tissues (×100 and ×200 magnifications, respectively). (b) Immunohistochemistry analysis of expression of KIF23 protein in the adjacent tissues (×100 and ×200 magnifications, respectively). (c) The difference analysis of the overall survival rate and disease-free survival rate between the low- and high-KIF23 expression groups: the median survival period of OS in the low- and high-KIF23 expression groups was 29.8 and 49.3 months, respectively, and the median survival period of DFS in the low- and high-KIF23 expression groups was 18.8 and 38.6 months, respectively.

(a)

(b)

(c)